PeerView Clinical Pharmacology CME/CNE/CPE Video

Mrinal Gounder, MD - Getting to Know the New Desmoid Tumor ICD-10-CM Codes and Why They Matter: Practical Guidance for Integrating the New Codes and Navigating the Implications

12.01.2023 - By PVI, PeerView Institute for Medical EducationPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/YNP865. CME credit will be available until November 26, 2024.Getting to Know the New Desmoid Tumor ICD-10-CM Codes and Why They Matter: Practical Guidance for Integrating the New Codes and Navigating the Implications In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from SpringWorks Therapeutics, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerMrinal Gounder, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Aadi bioscience; Ayala Pharmaceuticals; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Epizyme; Karyopharm Therapeutics; Rain Therapeutics; Regeneron Pharmaceuticals Inc.; SpringWorks Therapeutics; and TYME Inc.Grant/Research Support from Ayala Pharmaceuticals; Bayer AG; Iterion Therapeutics; and SpringWorks Therapeutics.Faculty/PlannerLinda Holtzman, MHA, RHIA, CCS, CCS-P, CPC, COC, has a financial interest/relationship or affiliation in the form of:Other Financial or Material Support as an Independent Contractor for Desmoid Tumor Research Foundation.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

More episodes from PeerView Clinical Pharmacology CME/CNE/CPE Video